FASTKD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.384380E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.755570E-01
Normal-vs-Stage2
5.613000E-04
Normal-vs-Stage3
1.189980E-01
Normal-vs-Stage4
6.010000E-02
Stage1-vs-Stage2
9.678400E-02
Stage1-vs-Stage3
5.249800E-01
Stage1-vs-Stage4
2.583400E-01
Stage2-vs-Stage3
7.234000E-01
Stage2-vs-Stage4
6.831800E-01
Stage3-vs-Stage4
6.476400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.682270E-03
Normal-vs-AfricanAmerican
4.835600E-02
Normal-vs-Asian
2.580100E-02
Caucasian-vs-AfricanAmerican
8.543400E-01
Caucasian-vs-Asian
8.500200E-01
AfricanAmerican-vs-Asian
8.025200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.232300E-04
Normal-vs-Female
7.977600E-03
Male-vs-Female
1.733790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.371960E-01
Normal-vs-Age(41-60Yrs)
1.864670E-03
Normal-vs-Age(61-80Yrs)
3.043200E-03
Normal-vs-Age(81-100Yrs)
2.358100E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.338200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.753600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.650800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.978400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.138200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.960600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.397300E-04
Normal-vs-Daily Drinker
9.663000E-03
Normal-vs-Weekly Drinker
2.791600E-02
Normal-vs-Occasional Drinker
3.535900E-02
Normal-vs-Social Drinker
7.789600E-04
Non Drinker-vs-Daily Drinker
2.293000E-01
Non Drinker-vs-Weekly Drinker
7.041900E-02
Non Drinker-vs-Occasional Drinker
5.967800E-02
Non Drinker-vs-Social Drinker
8.845400E-01
Daily Drinker-vs-Weekly Drinker
5.018600E-01
Daily Drinker-vs-Occasional Drinker
4.770600E-01
Daily Drinker-vs-Social Drinker
3.433200E-01
Weekly Drinker-vs-Occasional Drinker
9.826600E-01
Weekly Drinker-vs-Social Drinker
1.050650E-01
Occasional Drinker-vs-Social Drinker
1.144030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.628000E-01
Normal-vs-Grade 2
8.593200E-01
Normal-vs-Grade 3
8.593600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.498580E-01
Grade 1-vs-Grade 3
1.708240E-01
Grade 1-vs-Grade 4
9.628000E-01
Grade 2-vs-Grade 3
9.971000E-01
Grade 2-vs-Grade 4
8.593200E-01
Grade 3-vs-Grade 4
8.593600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.012400E-04
Normal-vs-NonDiabetic
2.361000E-03
Diabetic-vs-NonDiabetic
4.429900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.000000E-03
Normal-vs-NoPancreatitis
1.055350E-03
Pancreatitis-vs-NoPancreatitis
2.231600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.577900E-03
Normal-vs-N1
1.024140E-03
N0-vs-N1
4.271400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.681800E-03
Normal-vs-TP53-NonMutant
1.325760E-02
TP53-Mutant-vs-TP53-NonMutant
4.798000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
